Alzheimer Disease Clinical Trials in Philadelphia, Pennsylvania

4 studies are recruiting for alzheimer disease in Philadelphia, Pennsylvania right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders

    The goal of this clinical trial is to compare the Hospital Elder Life Program (HELP) with a family-augmented version of HELP (FAM-HELP), that includes family members and care partners, for the prevention of delirium in older patients during hospital admission. The main objectives of the trial are t…

    Stage
    Not phased
    Ages
    70 and older
    Site
    Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania
    Locations
    7 in total
    Run by
    University of Michigan

    See if you can join NCT05929703 on ClinicalTrials.gov

  2. Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

    This is a study to evaluate the efficacy, safety, and tolerability of BMS-986368, a FAAH/MAGL inhibitor, for the treatment of agitation in participants with Alzheimer's Disease.

    Stage
    Phase 2
    Ages
    55 to 90
    Site
    Thomas Jefferson University - Vickie & Jack Farber Institute for Neuroscience, Philadelphia, Pennsylvania
    Locations
    78 in total
    Run by
    Celgene

    See if you can join NCT06808984 on ClinicalTrials.gov

  3. Using the EHR to Advance Genomic Medicine Across a Diverse Health System

    Given the expansion of indications for genetic testing and our understanding of conditions for which the results change medical management, it is imperative to consider novel ways to deliver care beyond the traditional genetic counseling visit, which are both amenable to large-scale implementation …

    Stage
    Not phased
    Ages
    18 and older
    Site
    Penn Medicine, Philadelphia, Pennsylvania
    Run by
    University of Pennsylvania

    See if you can join NCT06377033 on ClinicalTrials.gov

  4. PET Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Using [18F]-PI-2620

    The investigators will compare [18F]-PI-2620 tau PET scans from patients with frontotemporal lobar degeneration (FTLD), patients with non-amnestic presentations of Alzheimer's disease (naAD), and demographically matched cognitively normal subjects.

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Perelman Center for Advance Medicine, Philadelphia, Pennsylvania
    Run by
    University of Pennsylvania

    See if you can join NCT05456503 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.